Prognostication and molecular regulation of acute myeloid leukemia: An integration of bioinformatics and clinical medicine

In biomedical research, high-throughput genomic technologies, such as DNA microarrays and next-generation sequencing, can investigate millions of gene features in a short time. However, to comprehensively analyze such big data and dissect biologically and clinically crucial information has emerged to be a challenging task. In my talk, I will present our recent studies in acute myeloid leukemia (AML) as a showcase for demonstrating how an integration of bioinformatics and clinical medicine can contribute to translation medicine.